Login | Register

Medical News Today: New inhaled drug for COPD wins FDA approval

The FDA have approved the once-daily inhaled drug olodaterol (brand name Striverdi Respimat), a long-acting beta-agonist, for the treatment of airflow obstruction in COPD patients.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *